News & Blogs

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]

EFI 2023 - Bienvenue à Nantes, France!

Immucor is excited to see you at EFI 2023 - Bienvenue à Nantes, France! As a Platinum Level sponsor, we will be sharing our latest innovations at the 36th European Immunogenetics and Histocompatibility Conference (EFI). EFI will be held live […]

Corporate Social Responsibility

Immucor is dedicated to supporting our global and local communities and environments through the giving of our time, talents and money in order to transform a life. With sites located throughout the world, Immucor provides the support needed for all […]

CYBERSECURITY is never a destination. It is a journey we are on together.

At Immucor, we are dedicated to protecting our products and the data they contain against malicious threats to confidentiality, integrity, availability and feel strongly that cybersecurity is a shared responsibility between Immucor and our customers. In order to better assist […]

Automated Extended Phenotype Assays are now available on the NEO Iris®/NEO® (v2.0)!

Is your laboratory impacted by staffing shortages and struggling to perform critical time consuming tasks, such as phenotyping donor units to attain antigen negative red cell units? Are you forced to order from a local reference lab? How does this […]